Literature DB >> 20392831

Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells.

Man-Tat Lau1, Alice S T Wong, Peter C K Leung.   

Abstract

Gonadotropins (FSH and LH) are detectable in ovarian tumor fluid, suggesting a possible role for gonadotropins in ovarian carcinogenesis and progression. However, the molecular mechanisms behind the role of gonadotropins in ovarian cancer development are unknown. Cyclooxygenase (COX) enzymes, COX-1 and COX-2, play crucial roles in the pathogenesis of human malignancies. The purpose of the current study was to determine whether the effect of gonadotropins on ovarian cancer invasion is mediated by a COX-dependent mechanism. Here, we reported that FSH/LH can promote prostaglandin E(2) (PGE(2)) production in ovarian cancer cells via COX-1 and -2 up-regulation at the protein and mRNA level. The phosphatidylinositol-3-kinase (PI3K)/AKT signaling pathway was required for gonadotropin-mediated up-regulation of COX-1 and COX-2. Moreover, treatment with COX-1- and COX-2-specific inhibitors abrogated the stimulatory effect of gonadotropins on motility and invasive activity. Western blot and gelatin zymography showed that COX-1 and COX-2 were critical for gonadotropin-induced expression of metastasis-related proteinases, matrix metalloproteinase (MMP)-2 and MMP-9. In addition, our results showed that PGE(2) induced an increase in cell invasiveness and the expression of MMP-2 and MMP-9 in ovarian cancer cells. These data show that COX-1 and COX-2 play essential roles in gonadotropin-induced migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392831     DOI: 10.1210/en.2009-1318

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein.

Authors:  Marie-Claude Déry; Parvesh Chaudhry; Valérie Leblanc; Sophie Parent; Anne-Marie Fortier; Eric Asselin
Journal:  Biol Reprod       Date:  2011-08-03       Impact factor: 4.285

Review 2.  Microenvironment and pathogenesis of epithelial ovarian cancer.

Authors:  Antonio F Saad; Wei Hu; Anil K Sood
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

Review 3.  Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

Authors:  Kannan Badri Narayanan; Manaf Ali; Barry J Barclay; Qiang Shawn Cheng; Leandro D'Abronzo; Rita Dornetshuber-Fleiss; Paramita M Ghosh; Michael J Gonzalez Guzman; Tae-Jin Lee; Po Sing Leung; Lin Li; Suidjit Luanpitpong; Edward Ratovitski; Yon Rojanasakul; Maria Fiammetta Romano; Simona Romano; Ranjeet K Sinha; Clement Yedjou; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Elizabeth P Ryan; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Hosni K Salem; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Seo Yun Kim; William H Bisson; Leroy Lowe; Hyun Ho Park
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

4.  Follicle-stimulating hormone enhances alveolar bone resorption via upregulation of cyclooxygenase-2.

Authors:  Chunxia Zhu; Yaoting Ji; Shengbo Liu; Zhuan Bian
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

5.  FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.

Authors:  Xiang Tao; Naiqing Zhao; Hongyan Jin; Zhenbo Zhang; Yintao Liu; Jian Wu; Robert C Bast; Yinhua Yu; Youji Feng
Journal:  Endocr Relat Cancer       Date:  2013-05-30       Impact factor: 5.678

6.  Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.

Authors:  Di Wang; Xiao-Zhong Guo; Hong-Yu Li; Jia-Jun Zhao; Xiao-Dong Shao; Chun-Yan Wu
Journal:  Tumour Biol       Date:  2014-07-18

7.  Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.

Authors:  Juan Cui; Brooke M Miner; Joanna B Eldredge; Susanne W Warrenfeltz; Phuongan Dam; Ying Xu; David Puett
Journal:  BMC Cancer       Date:  2011-06-28       Impact factor: 4.430

8.  Repurposing 11C-PS13 for PET Imaging of Cyclooxygenase-1 in Ovarian Cancer Xenograft Mouse Models.

Authors:  Amanda J Boyle; Junchao Tong; Sami S Zoghbi; Victor W Pike; Robert B Innis; Neil Vasdev
Journal:  J Nucl Med       Date:  2020-09-25       Impact factor: 10.057

9.  Progression of choroidal metastasis of ovarian serous cystoadenocarcinoma after intravitreal bevacizumab treatment.

Authors:  Irene C Kuo; Ruben H Sambuelli; Javier Bono; Ricardo J Smith; Victor E Reviglio
Journal:  Rare Tumors       Date:  2013-03-04

10.  Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.

Authors:  Zhenbo Zhang; Yaping Zhu; Yunli Lai; Xiaomei Wu; Zhengzhong Feng; Yinhua Yu; Robert C Bast; Xiaoping Wan; Xiaowei Xi; Youji Feng
Journal:  Int J Oncol       Date:  2013-08-06       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.